Skip to search formSkip to main contentSkip to account menu

RotaTeq

National Institutes of Health

Related topics

Related topics

6 relations

Broader (5)

Human-Bovine Reassortant Rotavirus Strain G3 VaccineHuman-Bovine Reassortant Rotavirus Strain G4 VaccineRotavirus VaccinesVaccines, Attenuated
RotaTeq Oral Product

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis.
2016
2016
One-step multiplex real-time RT-PCR assay for detecting and genotyping wild-type group A rotavirus strains and vaccine strains (Rotarix® and RotaTeq®) in stool samples
Background. Group A rotavirus (RVA) infection is the major cause of acute gastroenteritis (AGE) in young children worldwide… 
Highly Cited
2013
Highly Cited
2013
Real-time RT-PCR assays to differentiate wild-type group A rotavirus strains from Rotarix® and RotaTeq® vaccine strains in stool samples
Group A rotaviruses (RVA) are the leading cause of severe diarrhea in young children worldwide. Two live-attenuated RVA vaccines… 
Highly Cited
2013
Highly Cited
2013
Impact and Effectiveness of RotaTeq® Vaccine Based on 3 Years of Surveillance Following Introduction of a Rotavirus Immunization Program in Finland
Background: Finland introduced universal rotavirus (RV) vaccination in September 2009, with exclusive use of the pentavalent… 
Highly Cited
2012
Highly Cited
2012
Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination.
BACKGROUND RotaTeq vaccine was introduced into the Australian National Immunisation Program in 2007. This study identified and… 
Highly Cited
2012
Highly Cited
2012
Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua.
Highly Cited
2011
Highly Cited
2011
Genetic Analyses Reveal Differences in the VP7 and VP4 Antigenic Epitopes between Human Rotaviruses Circulating in Belgium and Rotaviruses in Rotarix and RotaTeq
ABSTRACT Two live-attenuated rotavirus group A (RVA) vaccines, Rotarix (G1P[8]) and RotaTeq (G1-G4, P[8]), have been successfully… 
Highly Cited
2011
Highly Cited
2011
Distribution of Rotavirus Genotypes After Introduction of Rotavirus Vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia
Background: Rotavirus vaccines, RotaTeq and Rotarix, were introduced into the Australian National Immunization Program on July 1… 
Highly Cited
2008
Highly Cited
2008
Postlicensure Monitoring of Intussusception After RotaTeq Vaccination in the United States, February 1, 2006, to September 25, 2007
BACKGROUND. In 1999, a previous rotavirus vaccine (RotaShield; Wyeth Laboratories, Marietta, PA) was withdrawn from the US market… 
Review
2006
Review
2006
The pentavalent rotavirus vaccine, RotaTeq.
Vaccination against rotavirus disease has been a global preventive health priority since rotaviruses were first discovered in the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)